University of Phoenix
MBA 560 Week 6
Written 11/29/2007
1,262 Words
WEEK6: Corporate Compliance Report
Bone marrow and cord blood transplants are a life-changing treatment for people with leukemia, lymphoma and many other diseases. For many patients, a transplant may be the best — and only — hope for a cure. When patients learn they need a transplant, they turn first to their families to find a donor. But 70% of those patients won’t find a suitable match in their family. They depend on bone marrow or cord blood donors like you.
The National Marrow Donor Program (NMDP) makes sure every patient has the best possible chance to receive the transplant he or she needs. A national non-profit organization in the business of matching patients in need of a marrow, stem cell or cord blood transplant with matching donors willing to voluntarily donate to those in need.
The National Marrow Donor Program is headquartered out of Minneapolis, Minnesota with NMDP owned donor centers in every state of the U.S. and nine foreign countries. The NMDP has over 300 employees located in Minneapolis and 900 employees organizational wide.
The National Marrow Donor Program has a Quality Control department operating out of Minneapolis that handles risk management issues for the entire organization. As with all organizations, the COSO recommendations for internal controls should be very important and if I were to implement the recommendations into our organization these are the key issues that would be implemented.
Applying COSO to practice is not as simple as adopting it in theory, however. No defined approach exists for auditing "soft" controls like the integrity and ethical values of staff, the philosophy and operating s ...